Summary#
This bill would stop any entity that received money from certain federal COVID relief laws from requiring employees to get a COVID‑19 vaccine. Its main change is a blanket ban on vaccine mandates for employees by those fund recipients, with a penalty of returning the funds if the ban is violated. The stated broad policy aim is to limit employer vaccine mandates tied to those specific COVID relief programs.
- Main change: Any entity that receives funds from the listed COVID relief packages may not require employees to get a COVID‑19 vaccine.
- Penalty: An entity that violates the ban must return the COVID relief funds it received.
- Which funds are covered: The bill lists six specific laws (for example, the CARES Act and the American Rescue Plan Act of 2021).
- What is unclear: The bill does not define “entity” in detail (for example, whether it includes state or local governments, contractors, hospitals, universities, nonprofits, or private businesses in all cases). It also does not explain how the return-of-funds penalty would be enforced, the timing for repayment, or whether partial violations trigger partial repayment.
What it means for you#
- Employers and organizations that got these funds: They would not be allowed to require employees to have a COVID‑19 vaccine. If they do require vaccination, the employer would be required to return the COVID relief funds it received (according to the bill).
- Employees: If your employer received money from one of the named COVID relief laws, your employer would be prohibited from making a COVID‑19 vaccine a condition of employment under this bill.
- Businesses and nonprofits applying for or using those funds: They may need to review their workplace health policies and any existing vaccine requirements to avoid the risk of having to return funds.
- Public agencies and institutions: It is unclear whether all public agencies are covered; the bill’s broad wording suggests many recipients could be affected, but the text does not spell out categories or exceptions.
- Workers in health or safety‑sensitive jobs: The bill does not address how other workplace health and safety rules would interact with this ban; the effect on job-specific safety requirements is not specified.
Expenses#
No publicly available information.
- The bill requires repayment of COVID relief funds by entities that violate the ban. The bill does not estimate how often that would occur or the total fiscal effect.
- Possible practical costs (not estimated in the bill): administrative costs to review and change employer policies; legal or compliance costs if repayment disputes arise; and potential loss of federal funding for entities that choose to keep vaccine mandates.
- The bill does not include a federal enforcement budget, staffing plan, or mechanism for recovering funds beyond the repayment requirement in the text.
Proponents' View#
- The bill appears intended to stop employers who received COVID relief money from forcing employees to get vaccinated.
- A possible argument for the bill is that it protects individual choice about COVID‑19 vaccination for employees of entities that benefited from those federal relief programs.
- The bill provides a clear penalty (return of funds) for entities that impose mandates, which could be seen as a strong compliance incentive.
Opponents' View#
- One concern is that the bill does not define “entity” clearly, which could create confusion about which organizations are covered and lead to legal disputes.
- The bill does not explain how repayment would be enforced, what the timeline would be, or how to handle partial or disputed cases.
- A possible trade-off is that some employers may be unable to implement workplace health rules (for example, in health care settings) if those rules are treated as vaccine mandates, with potential effects on workplace safety; the bill does not address how to reconcile that.
- The bill could prompt administrative or legal costs for recipients and the federal government to resolve compliance questions, but it offers no budget or enforcement details.